PENTA 11

This is a long term follow-up study assessing whether children with HIV infection undergoing planned ART…

Evaluation of Novel Concepts in Optimization of antiRetroviral Efficacy (ENCORE1)

A randomized, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose (400mg)…

Reproductive health and HIV – Characterize HIV serodiscordance in heterosexual couples

This is a cross-sectional study to gather data on the marital status or engagement in a…

Tenofovir pharmacokinetics in HIV-infected Thai adults with moderate renal function impairment receiving either a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based or Lopinavir/Ritonavir-based antiretroviral therapy

The study is a phase I, non-randomized, open-label, pharmacokinetic study to evaluate the pharmacokinetics of tenofovir…

Bone mineral density across puberty stage among HIV-infected adolescents receiving antiretroviral therapy

This is a cross-sectional study to assess the changes of the bone mass among HIV-infected adolescents…

Bone and body comp: A sub study of SECOND-LINE study

Description: n/a

Characteristics and clinical significances of hepatitis C genotype in HIV- and hepatitis C co-infected Thai patients

This is a cross-sectional study that will assess the HCV genotype and gene interleukin 28 (IL-28)…

A Kaletra ONCE daily randomized trial of the pharmacokinetics, safety and efficacy of twice-daily versus once-daily Lopinavir/Ritonavir tablets dosed by weight as part of combination antiretroviral therapy in HIV-1 infected children

This study will evaluate once daily lopinavir/ritonavir-based HAART in virological suppressed children.

A randomized open-label study comparing the safety and efficacy of Ritonavir boosted Lopinavir and 2-3N(t)RTI backbone versus Ritonavir boosted Lopinavir and Raltegravir in participants virologically failing first-line NNRTI/2N(t)RTI therapy: the SECOND-LINE study

This is a Phase IIIb/IV, international, randomized, open label study comparing two regimens of combination antiretroviral…

LASA HAIR substudy

This study will evaluate the atazanavir/ritonavir concentration in hair

PREDICT sub study- PREDICT cohort

Extension for HIV-NAT 035

The effect of immediate versus deferred antiretroviral initiation on neurodevelopment in children with HIV in Cambodia and Thailand

This sub study assesses the effect of immediate versus deferred antiretroviral initiation on neurodevelopment in children…

CNS substudy

A randomised, double‐blind, placebo‐controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz…

PK substudy

A randomised, double‐blind, placebo‐controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz…

Low dose Atazanavir/r vs. Standard dose Atazanavir/r (LASA)

A multicenter randomized study to compare the efficacy and safety of lower dose atazanavir/ritonavir (ATV/r 200/100…